New Age Alpha Advisors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113K Sell
1,694
-64
-4% -$5.42K ﹤0.01% 833
2026
Q1
$175K Sell
1,758
-42
-2% -$5.48K 0.01% 639
2025
Q4
$219K Buy
1,800
+4
+0.2% +$502 0.01% 594
2025
Q3
$202K Sell
1,796
-30
-2% -$3.51K 0.01% 634
2025
Q2
$245K Buy
1,826
+113
+7% +$12.4K 0.01% 590
2025
Q1
$115K Sell
1,713
-1,129
-40% -$77.7K 0.01% 726
2024
Q4
$177K Buy
+2,842
New +$265K 0.01% 676

Other funds holding TMDX

New Age Alpha Advisors's TMDX Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Transmedics (TMDX) stake by 3.6% in Q2 2026, selling an estimated $5.42K and leaving 1,694 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

New Age Alpha Advisors first reported a position in TMDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $245K in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • New Age Alpha Advisors held 1,694 shares of Transmedics worth $113K as of Q2 2026.
  • New Age Alpha Advisors sold 64 Transmedics shares in Q2 2026, an estimated $5.42K.
  • Transmedics made up ﹤0.01% of New Age Alpha Advisors's portfolio in Q2 2026, its #833 holding.
  • New Age Alpha Advisors first reported a position in Transmedics in Q4 2024 and has held it in 7 quarters since.
  • New Age Alpha Advisors's Transmedics position peaked at $245K in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.